- Home
- SVM vs NVCR Comparison
SVM vs NVCR Comparison
Compare SVM & NVCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVM
- NVCR
- Stock Information
- Founded
- SVM N/A
- NVCR 2000
- Country
- SVM Canada
- NVCR Switzerland
- Employees
- SVM N/A
- NVCR N/A
- Industry
- SVM Precious Metals
- NVCR Medical/Dental Instruments
- Sector
- SVM Basic Materials
- NVCR Health Care
- Exchange
- SVM Nasdaq
- NVCR Nasdaq
- Market Cap
- SVM 1.4B
- NVCR 1.3B
- IPO Year
- SVM N/A
- NVCR 2015
- Fundamental
- Price
- SVM $6.60
- NVCR $11.25
- Analyst Decision
- SVM Strong Buy
- NVCR Buy
- Analyst Count
- SVM 1
- NVCR 7
- Target Price
- SVM $6.75
- NVCR $28.64
- AVG Volume (30 Days)
- SVM 5.3M
- NVCR 1.5M
- Earning Date
- SVM 11-06-2025
- NVCR 10-30-2025
- Dividend Yield
- SVM 0.38%
- NVCR N/A
- EPS Growth
- SVM N/A
- NVCR N/A
- EPS
- SVM 0.12
- NVCR N/A
- Revenue
- SVM $323,391,000.00
- NVCR $642,269,000.00
- Revenue This Year
- SVM $18.81
- NVCR $9.54
- Revenue Next Year
- SVM $31.23
- NVCR $5.70
- P/E Ratio
- SVM $57.16
- NVCR N/A
- Revenue Growth
- SVM 33.99
- NVCR 11.17
- 52 Week Low
- SVM $2.87
- NVCR $10.70
- 52 Week High
- SVM $7.78
- NVCR $34.13
- Technical
- Relative Strength Index (RSI)
- SVM 52.01
- NVCR 35.05
- Support Level
- SVM $6.33
- NVCR $10.70
- Resistance Level
- SVM $7.20
- NVCR $12.01
- Average True Range (ATR)
- SVM 0.33
- NVCR 0.57
- MACD
- SVM 0.02
- NVCR -0.11
- Stochastic Oscillator
- SVM 51.63
- NVCR 15.48
About SVM Silvercorp Metals Inc.
Silvercorp Metals Inc is a mineral exploration company, engaged in the acquisition, exploration, development, and mining of mineral properties. The company's producing mines are located in China, and exploration and development projects are located in China and Ecuador. Its project portfolio comprises the El Domo copper-gold and the Condor gold project in Ecuador. In addition, it operates several silver-lead-zinc mines at the Ying Mining District in Henan Province, China, and the GC silver-lead-zinc mine in Guangdong Province, China. A majority of the company's revenue is generated through the sale of silver concentrates. Its reportable operating segments are the Ying Mining District and GC Mine in China, which derive maximum revenue, and the El Domo and Condor projects in Ecuador.
About NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a propreitary platform technology in United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.